{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:23:15Z","timestamp":1794248595374,"version":"4.9.0"},"reference-count":71,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Province Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.isci.2026.116732","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T23:54:15Z","timestamp":1783727655000},"page":"116732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune-associated alternative splicing signatures define molecular subtypes in breast cancer"],"prefix":"10.1016","volume":"29","author":[{"given":"Yaran","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6621-7064","authenticated-orcid":false,"given":"Qiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2026.116732_bib1","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.isci.2026.116732_bib2","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0140-6736(16)31891-8","article-title":"Breast cancer","volume":"389","author":"Harbeck","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2026.116732_bib3","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.isci.2026.116732_bib4","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1056\/NEJMra1001389","article-title":"Triple-negative breast cancer","volume":"363","author":"Foulkes","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2026.116732_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biochem.72.121801.161720","article-title":"Mechanisms of alternative pre-messenger RNA splicing","volume":"72","author":"Black","year":"2003","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.isci.2026.116732_bib6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1038\/ng.259","article-title":"Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing","volume":"40","author":"Pan","year":"2008","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116732_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/onc.2013.570","article-title":"Alternative splicing in cancer: implications for biology and therapy","volume":"34","author":"Chen","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.isci.2026.116732_bib8","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrm2777","article-title":"Mechanisms of alternative splicing regulation: insights from molecular and genomics approaches","volume":"10","author":"Chen","year":"2009","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2026.116732_bib9","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/ijms17010003","article-title":"The Role of Alternative Splicing in the Control of Immune Homeostasis and Cellular Differentiation","volume":"17","author":"Yabas","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2026.116732_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/imr.12047","article-title":"Control of alternative splicing in immune responses: many regulators, many predictions, much still to learn","volume":"253","author":"Martinez","year":"2013","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.isci.2026.116732_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neuron.2015.05.004","article-title":"Alternative Splicing in the Mammalian Nervous System: Recent Insights into Mechanisms and Functional Roles","volume":"87","author":"Raj","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.isci.2026.116732_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrn.2016.27","article-title":"The neurogenetics of alternative splicing","volume":"17","author":"Vuong","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.isci.2026.116732_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/MOH.0000000000000329","article-title":"RNA splicing during terminal erythropoiesis","volume":"24","author":"Conboy","year":"2017","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.isci.2026.116732_bib14","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature14351","article-title":"MYC regulates the core pre-mRNA splicing machinery as an essential step in lymphomagenesis","volume":"523","author":"Koh","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116732_bib15","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1261\/rna.042259.113","article-title":"Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development","volume":"20","author":"Shilo","year":"2014","journal-title":"RNA"},{"key":"10.1016\/j.isci.2026.116732_bib16","doi-asserted-by":"crossref","first-page":"7103","DOI":"10.1038\/ncomms8103","article-title":"Inhibition of vemurafenib-resistant melanoma by interference with pre-mRNA splicing","volume":"6","author":"Salton","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116732_bib17","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1158\/0008-5472.CAN-17-3514","article-title":"PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer Progression","volume":"78","author":"Zheng","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.isci.2026.116732_bib18","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1136\/gutjnl-2017-314983","article-title":"SRSF6-regulated alternative splicing that promotes tumour progression offers a therapy target for colorectal cancer","volume":"68","author":"Wan","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.isci.2026.116732_bib19","doi-asserted-by":"crossref","first-page":"11396","DOI":"10.1093\/nar\/gky921","article-title":"Modulation of MKNK2 alternative splicing by splice-switching oligonucleotides as a novel approach for glioblastoma treatment","volume":"46","author":"Mogilevsky","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib20","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ncb3538","article-title":"The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1","volume":"19","author":"Yuan","year":"2017","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.isci.2026.116732_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.149135","article-title":"PD-L1 splice variant-driven soluble PD-L1 secretion promotes immune evasion in gastric cancer","volume":"334","author":"Jiang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.isci.2026.116732_bib22","article-title":"Human inherited PD-L1 deficiency is clinically and immunologically less severe than PD-1 deficiency","volume":"221","author":"Johnson","year":"2024","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.isci.2026.116732_bib23","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41568-022-00541-7","article-title":"RNA splicing dysregulation and the hallmarks of cancer","volume":"23","author":"Bradley","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116732_bib24","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","article-title":"Pharmacologic modulation of RNA splicing enhances anti-tumor immunity","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2026.116732_bib25","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"Tomczak","year":"2015","journal-title":"Contemp. Oncol."},{"key":"10.1016\/j.isci.2026.116732_bib26","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gku121","article-title":"Isoform-level gene signature improves prognostic stratification and accurately classifies glioblastoma subtypes","volume":"42","author":"Pal","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib27","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.canlet.2017.02.016","article-title":"Prognostic alternative mRNA splicing signature in non-small cell lung cancer","volume":"393","author":"Li","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.isci.2026.116732_bib28","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.ygyno.2017.11.028","article-title":"Systematic profiling of alternative splicing signature reveals prognostic predictor for ovarian cancer","volume":"148","author":"Zhu","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.isci.2026.116732_bib29","doi-asserted-by":"crossref","first-page":"D125","DOI":"10.1093\/nar\/gks997","article-title":"SpliceAid-F: a database of human splicing factors and their RNA-binding sites","volume":"41","author":"Giulietti","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/75556","article-title":"Gene ontology: tool for the unification of biology. The Gene Ontology Consortium","volume":"25","author":"Ashburner","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2026.116732_bib31","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2026.116732_bib32","doi-asserted-by":"crossref","first-page":"W534","DOI":"10.1093\/nar\/gkaf388","article-title":"TIMER3: an enhanced resource for tumor immune analysis","volume":"53","author":"Cui","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib33","doi-asserted-by":"crossref","first-page":"3667","DOI":"10.1016\/j.molcel.2024.07.019","article-title":"Molecular impact of mutations in RNA splicing factors in cancer","volume":"84","author":"Zhang","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116732_bib34","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.molcel.2021.01.034","article-title":"Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancer","volume":"81","author":"Cie\u015bla","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2026.116732_bib35","doi-asserted-by":"crossref","first-page":"D672","DOI":"10.1093\/nar\/gkad1025","article-title":"The Reactome Pathway Knowledgebase 2024","volume":"52","author":"Milacic","year":"2024","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib36","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The Immune Landscape of Cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2026.116732_bib37","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202012118","article-title":"The mutational landscape of the SCAN-B real-world primary breast cancer transcriptome","volume":"12","author":"Brueffer","year":"2020","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.isci.2026.116732_bib38","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrg2776","article-title":"Alternative splicing and evolution: diversification, exon definition and function","volume":"11","author":"Keren","year":"2010","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.isci.2026.116732_bib39","doi-asserted-by":"crossref","first-page":"GEG.S35500","DOI":"10.4137\/GEG.S35500","article-title":"Aberrant Splicing of Estrogen Receptor, HER2, and CD44 Genes in Breast Cancer","volume":"7","author":"Inoue","year":"2015","journal-title":"Genet. Epigenet."},{"key":"10.1016\/j.isci.2026.116732_bib40","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1172\/JCI44540","article-title":"CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression","volume":"121","author":"Brown","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.isci.2026.116732_bib41","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1002\/ijc.30574","article-title":"Novel splice-switching oligonucleotide promotes BRCA1 aberrant splicing and susceptibility to PARP inhibitor action","volume":"140","author":"Smith","year":"2017","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.isci.2026.116732_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2018.07.008","article-title":"Cancer-Specific Splicing Changes and the Potential for Splicing-Derived Neoantigens","volume":"34","author":"Hoyos","year":"2018","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2026.116732_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1158\/1541-7786.MCR-09-0528","article-title":"Exon-level microarray analyses identify alternative splicing programs in breast cancer","volume":"8","author":"Lapuk","year":"2010","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.isci.2026.116732_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002218","article-title":"An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype","volume":"7","author":"Shapiro","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.isci.2026.116732_bib45","doi-asserted-by":"crossref","first-page":"bgz073","DOI":"10.1093\/carcin\/bgz073","article-title":"Prognostic alternative mRNA splicing signature in hepatocellular carcinoma: a study based on large-scale sequencing data","volume":"40","author":"Zhu","year":"2019","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.isci.2026.116732_bib46","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ebiom.2018.09.021","article-title":"Profiles of alternative splicing in colorectal cancer and their clinical significance: A study based on large-scale sequencing data","volume":"36","author":"Xiong","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.isci.2026.116732_bib47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s13046-017-0574-5","article-title":"Wogonoside inhibits invasion and migration through suppressing TRAF2\/4 expression in breast cancer","volume":"36","author":"Yao","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.isci.2026.116732_bib48","doi-asserted-by":"crossref","first-page":"8366","DOI":"10.1073\/pnas.1701289114","article-title":"Internalized CD44s splice isoform attenuates EGFR degradation by targeting Rab7A","volume":"114","author":"Wang","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116732_bib49","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12943-019-0946-x","article-title":"circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer","volume":"18","author":"Tang","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.isci.2026.116732_bib50","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nrc2439","article-title":"MYB function in normal and cancer cells","volume":"8","author":"Ramsay","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2026.116732_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkaf1171","article-title":"Single-cell mapping of alternative splicing linked to checkpoint immunotherapy response","volume":"53","author":"Xiong","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib52","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1093\/bioinformatics\/bts452","article-title":"SpliceSeq: a resource for analysis and visualization of RNA-Seq data on alternative splicing and its functional impacts","volume":"28","author":"Ryan","year":"2012","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib53","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13059-018-1417-1","article-title":"SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions","volume":"19","author":"Trincado","year":"2018","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.116732_bib54","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2026.116732_bib55","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2026.116732_bib56","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btae615","article-title":"DAVID Ortholog: an integrative tool to enhance functional analysis through orthologs","volume":"40","author":"Sherman","year":"2024","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib57","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2026.116732_bib58","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/bioinformatics\/btx364","article-title":"UpSetR: an R package for the visualization of intersecting sets and their properties","volume":"33","author":"Conway","year":"2017","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib59","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1038\/s41596-024-01020-z","article-title":"Using clusterProfiler to characterize multiomics data","volume":"19","author":"Xu","year":"2024","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.isci.2026.116732_bib60","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2026.116732_bib61","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1101\/gr.239244.118","article-title":"Maftools: efficient and comprehensive analysis of somatic variants in cancer","volume":"28","author":"Mayakonda","year":"2018","journal-title":"Genome Res."},{"key":"10.1016\/j.isci.2026.116732_bib62","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib63","doi-asserted-by":"crossref","first-page":"709","DOI":"10.12688\/f1000research.24956.2","article-title":"gprofiler2 -- an R package for gene list functional enrichment analysis and namespace conversion toolset g:Profiler","volume":"9","author":"Kolberg","year":"2020","journal-title":"F1000Res."},{"key":"10.1016\/j.isci.2026.116732_bib64","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/bioinformatics\/bth254","article-title":"PerlPrimer: cross-platform, graphical primer design for standard, bisulphite and real-time PCR","volume":"20","author":"Marshall","year":"2004","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib65","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.isci.2026.116732_bib66","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib67","doi-asserted-by":"crossref","first-page":"i884","DOI":"10.1093\/bioinformatics\/bty560","article-title":"fastp: an ultra-fast all-in-one FASTQ preprocessor","volume":"34","author":"Chen","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.isci.2026.116732_bib68","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1038\/s41587-019-0201-4","article-title":"Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype","volume":"37","author":"Kim","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.116732_bib69","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nbt.3122","article-title":"StringTie enables improved reconstruction of a transcriptome from RNA-seq reads","volume":"33","author":"Pertea","year":"2015","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2026.116732_bib70","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.isci.2026.116732_bib71","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2018.03.014","article-title":"A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers","volume":"33","author":"Berger","year":"2018","journal-title":"Cancer Cell"}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226021103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004226021103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T18:00:42Z","timestamp":1794247242000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004226021103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":71,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2589004226021103"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2026.116732","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune-associated alternative splicing signatures define molecular subtypes in breast cancer","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2026.116732","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"116732"}}